XML 21 R10.htm IDEA: XBRL DOCUMENT v3.25.3
Note C - Revenues
6 Months Ended
Sep. 28, 2025
Notes to Financial Statements  
Revenue from Contract with Customer [Text Block]

NOTE C – REVENUES

 

The Company’s disaggregated revenues for the thirteen and twenty-six weeks ended September 28, 2025 and September 29, 2024 are as follows (in thousands):

 

   

Thirteen weeks ended

   

Twenty-six weeks ended

 
   

September 28,

2025

   

September 29,

2024

   

September 28,

2025

   

September 29,

2024

 
                                 

Branded Products

  $ 29,047     $ 24,536     $ 58,122     $ 50,682  

Company-owned restaurants

    5,624       5,348       9,610       9,547  

License royalties

    9,227       9,491       21,608       22,412  

Franchise royalties

    1,138       1,066       2,139       2,047  

Franchise fees

    85       108       213       200  

Advertising fund revenue

    566       560       993       988  

Total revenues

  $ 45,687     $ 41,109     $ 92,685     $ 85,876  

 

The following table disaggregates revenues by primary geographical market (in thousands):

 

   

Thirteen weeks ended

   

Twenty-six weeks ended

 
   

September 28,

2025

   

September 29,

2024

   

September 28,

2025

   

September 29,

2024

 
                                 

United States

  $ 44,756     $ 40,464     $ 90,795     $ 83,760  

International

    931       645       1,890       2,116  

Total revenues

  $ 45,687     $ 41,109     $ 92,685     $ 85,876  

 

Contract balances

 

The following table provides information about contract liabilities from contracts with customers (in thousands):

 

   

September 28, 2025

   

March 30, 2025

 

Deferred franchise fees (a)

    $881       $1,006  

Deferred revenues, which are included in

               

“Accrued expenses and other current liabilities” (b)

    $715       $1,392  

 

 

(a)

Deferred franchise fees of $250 and $631 as of September 28, 2025 and $309 and $697 as of March 30, 2025 are included in Deferred franchise fees – current and long term, respectively.

 

(b)

Includes $215 of deferred license royalties and $500 of deferred advertising fund revenue as of September 28, 2025 and $892 of deferred license royalties and $500 of deferred advertising fund revenue as of March 30, 2025.

 

Significant changes in deferred franchise fees are as follows (in thousands):

 

   

Twenty-six weeks ended

 
   

September 28, 2025

   

September 29, 2024

 

Deferred franchise fees at beginning of period

  $ 1,006     $ 1,226  

New deferrals due to cash received and other

    88       75  

Revenue recognized during the period

    (213 )     (200 )

Deferred franchise fees at end of period

  $ 881     $ 1,101  

 

Significant changes in deferred revenues are as follows (in thousands):

 

   

Twenty-six weeks ended

 
   

September 28, 2025

   

September 29, 2024

 

Deferred revenues at beginning of period

  $ 1,392     $ 1,375  

New deferrals due to cash received and other

    500       500  

Revenue recognized during the period

    (1,177 )     (1,275 )

Deferred revenues at end of period

  $ 715     $ 600  

 

Anticipated future recognition of deferred franchise fees

 

The following table reflects the estimated franchise fees to be recognized in the future related to performance obligations that are unsatisfied at the end of the period (in thousands):

 

   

Estimate for fiscal year

 

2026 (a)

  $ 152  

2027

    196  

2028

    104  

2029

    77  

2030

    56  

Thereafter

    296  

Total

  $ 881  

 

 

(a)

Represents franchise fees expected to be recognized for the remainder of the 2026 fiscal year, which includes international development fees expected to be recognized over the duration of one year or less. Amount does not include $213 of franchise fee revenue recognized for the twenty-six weeks ended September 28, 2025.

 

We have applied the optional exemption, as provided for under ASC Topic 606 “Revenues from Contracts with Customers,” which allows us to not disclose the transaction price allocated to unsatisfied performance obligations when the transaction price is a sales-based royalty.